共 201 条
[1]
Bellin M(2016)Inherited heart disease – what can we expect from the second decade of human ips cell research? FEBS Lett 590 2482-2493
[2]
Mummery CL(2017)Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies DMM Dis Models Mech 10 1039-1059
[3]
Brandao KO(2016)Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy PLoS ONE 11 1-17
[4]
Tabel VA(2021)Increased tissue stiffness triggers contractile dysfunction and telomere shortening in dystrophic cardiomyocytes Stem Cell Rep 16 1-13
[5]
Atsma DE(2020)A miniaturized EHT platform for accurate measurements of tissue contractile properties J Microelectromech Syst 29 881-887
[6]
Mummery CL(2020)When stiffness matters: mechanosensing in heart development and disease Front Cell Dev Biol 8 1-16
[7]
Davis RP(2020)Human-IPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease Cell Stem Cell 26 862-879.e11
[8]
Cashman TJ(2021)Mimicking cardiac tissue complexity through physical cues: a review on cardiac tissue engineering approaches Nanomedicine 33 102367-986
[9]
Josowitz R(2015)Titin mutations in IPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy Science 349 982-13
[10]
Johnson BV(2012)Increased afterload induces pathological cardiac hypertrophy: a new in vitro model Basic Res Cardiol 107 307-17